Delivery of biomacromolecules e.g., insulin, GFs, small interfering RNA, as well as anti-diabetic chemical agents, is one of the most prominent features of NF–based structures for DM treatment [29, 30]. This evidence concerns the gene INS and diabetes mellitus.